These 5 pharma stocks can show a rise of up to 57%, Sharekhan recommends to buy
[ad_1]
Multibagger Stock: There was a big fall in the stock markets on Friday and the BSE Sensex fell 1,688 points. The domestic market fell with selling in global markets amid concerns over the new type of Kovid-19 virus. The 30-share BSE Sensex closed at 57,107.15 points, down 1,687.94 points, or 2.87 per cent. Similarly, the Nifty of the National Stock Exchange closed at 17,026.45, down 509.80 points, or 2.91 percent.
However, amidst all this, pharmaceutical stocks are expected to rise again, as investors worry that the pandemic may affect the economy in the coming days. During the first two waves of the pandemic, pharma stocks and IT stocks were the two major gainers in equity markets globally. However, pharma companies in Q2FY22 registered moderate revenue and earnings growth on a year-on-year basis as compared to Q1FY22.
Hence, investors can revisit pharma stocks. Again the demand for health care and hygiene items, medicines and vaccines may increase. With increasing demand and manufacturing, pharma stocks are expected to rise in this quarter. Nifty Pharma gained about 1.40 per cent even in a weak trading day yesterday.
We are telling you about 5 pharma stocks which brokerage firm Sharekhan has recommended to buy for good returns:-
Aurobindo Pharma (ARV)
- Target price Rs 875, expected to increase by 33%.
- Sharekhan, however, lowered the earnings estimates for ARVs by around 5% for both FY22E and FY23E.
Cipla
- 1,150, retains ‘Buy’ rating with a target price of Rs.
- Sharekhan has forecast a growth of 28%.
Cadila Healthcare
- Cadila Healthcare retains ‘Buy’ rating with a target price of Rs 720.
- Sharekhan has forecast a growth of 57%.
ipca laboratories
- Target Price: Rs 2,675.
- Sharekhan forecasts a growth of 30%.
Lupine (Lupine,
- Target Price: . 1,210
- Sharekhan has forecast a growth of 35%.
Disclaimer: (The information provided here is for informational purposes only. It is important to mention here that investing in the market is subject to market risks. Always consult an expert before investing money as an investor. Anyone from ABPLive.com Also investing money is never advised here.)
Read also:
Multibagger stock: Bumper Earnings! In 3 months this stock made 13 lakhs worth 1 lakh, gave 1200 percent return to investors
Earn money: By investing only 15000 rupees, you can also do this work, in 3 months you will earn 3 lakhs, know how?
,
[ad_2]